Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
JHC exPRESS: First Published May 27, 2005. doi:10.1369/jhc.4C6561.2005
Copyright © Histochemical Society, Inc.


A more recent version of this article appeared on October 1, 2005.
This Article
Right arrow exPRESS PDF
Right arrow All Versions of this Article:
jhc.4C6561.2005v1
53/10/1181    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bord, S.
Right arrow Articles by Compston, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bord, S.
Right arrow Articles by Compston, J. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Rapid Communications

Characterization of Osteocrin Expression in Human Bone

Sharyn Bord 1, Deborah C. Ireland 1, Pierre Moffatt 1, Gethin P. Thomas 1 and Juliet E. Compston 1*

1 Cambridge University School of Clinical Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom (SB,DCI,JEC), and Phenogene Therapeutics Inc., Montreal, Quebec, Canada (PM,GPT)

* To whom correspondence should be addressed. E-mail: jec1001{at}cam.ac.uk.

Submitted on October 26, 2004
Accepted on 4 May 2005


   Abstract
Osteocrin, a bone-active molecule, has been shown in animals to be highly expressed in cells of the osteoblast lineage. We have characterised this protein in human cultured primary human osteoblasts, in developing human neonatal bone and in iliac crest bone biopsies from adult women. In vivo, osteocrin expression was localized in developing human neonatal rib bone, with intense immunoreactivity in osteoblasts on bone forming surfaces, in newly incorporated osteocytes and in some late hypertrophic chondrocytes. In adult bone, osteocrin expression was specifically localized to osteoblasts and young osteocytes at bone forming sites. In vitro, osteocrin expression decreased time-dependently (p<0.02) in osteoblasts cultured for 2, 3 and 6 days. Expression was further decreased in cultures containing 200 nM hydrocortisone by 1.5-, 2.3- and 3.1-fold (p<0.05) at the same time points. In contrast, alkaline phosphatase expression increased with osteoblast differentiation (p<0.05). Low-dose oestradiol decreased osteocrin expression time-dependently (p<0.05), while osteocrin expression in cultures treated with high-dose oestradiol was not significantly changed. These results demonstrate that osteocrin is expressed in human skeletal tissue, particularly in osteoblasts in developing bone and at sites of bone remodelling, suggesting a role in bone formation. Thus osteocrin provides a marker of osteoblast lineage cells and appears to correlate with osteoblast activity.

Key Words: osteocrin, ostn, osteoblasts, osteocytes, human bone formation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
T. C R Prickett, G. K Barrell, M. Wellby, T. G Yandle, A M. Richards, and E. A Espiner
Effect of sex steroids on plasma C-type natriuretic peptide forms: stimulation by oestradiol in lambs and adult sheep
J. Endocrinol., December 1, 2008; 199(3): 481 - 487.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Moffatt, G. Thomas, K. Sellin, M.-C. Bessette, F. Lafreniere, O. Akhouayri, R. St-Arnaud, and C. Lanctot
Osteocrin Is a Specific Ligand of the Natriuretic Peptide Clearance Receptor That Modulates Bone Growth
J. Biol. Chem., December 14, 2007; 282(50): 36454 - 36462.
[Abstract] [Full Text] [PDF]




Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 2005